REFERENCES
- Khachaturian, Z.S. Diagnosis of Alzheimer's disease.Arch. Neurol. 1985, 42, 1097–1105., [PUBMED], [INFOTRIEVE], [CSA]
- Jorm, A.F.; Karten, A.E.; Henderson, A.S. The prevalence of dementia: a quantative integration of literature.Acta Physiol. Scand. 1987, 76, 465–479., [CSA]
- Coyle, J.T.; Price, D.L.; DeLong, M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation.Science 1983, 219, 1184–1190., [PUBMED], [INFOTRIEVE], [CSA]
- Pang, Y.-P.; Kozikowski, A.P. Prediction of the binding site of 1-benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine in acetylcholinesterase by docking studies with the SYSDOC program.J. Comput. Aid. Mol. Des. 1994, 8, 683–693., [CSA], [CROSSREF]
- Harel, M.; Schalk, I.; Ehresabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P.H.; Silman, I.; Sussman, J.L. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. P. Natl. Acad. Sci. USA. 1993, 90, 9031–9035., [CSA]
- Pang, Y.-P.; Quiram, P.; Jelacic, T.; Hong, F.; Brimijoin, S. Highly potent,selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase.J. Biol. Chem. 1996, 271, 23646–23649., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pang, Y.-P.; Hong, F.; Quiram, P.; Jelacic, T.; Brimijoin, S. Synthesis of alkylene linked bis-THA and alkylene linked benzyl-THA as highly potent and selective inhibitors and molecular probes of acetylcholinesterase.J. Chem. Soc., Perk. Trans. 1 1997, 171–176., [CSA], [CROSSREF]
- Chien, Y.W. Biopharmaceutics basis for transmucosal delivery.S.T.P. Pharma Sci. 1995, 5 (4), 257–275., [CSA]
- Qiao, G.L.; Williams, P.L.; Riviere, J.E. Percutaneous absorption, biotransformation, and systemic disposition of parathion in vivo in swine. I. Comprehensive pharmacokinetic model.Drug Metab. Dispos. 1994, 22, 459–471., [PUBMED], [INFOTRIEVE], [CSA]
- Reifernrath, W.G.; Hawkins, G.S.; Kurtz, M.S. Percutaneous penetration and skin retention of topically applied compounds: an in vitro–in vivo study.J. Pharm. Sci. 1991, 80, 526–532., [CSA]
- Chen, X.-Q.; Fawcett, J.R.; Rahman, Y.-E.; Ala, T.A.; Frey, W.H. Delivery of nerve growth factor to the brain via the olfactory pathway.Alzheimers Dis. 1998, 1, 35–44., [CSA]
- Chien, Y.W.; Valia, K. Development of a dynamic skin permeation system for long-term permeation studies.Drug Dev. Ind. Pharm. 1984, 10, 575–599., [CSA]
- Albert, A.; Serjeant, E.P. The Determination of Ionization Constants, 3rd Ed.; Chapman & Hall Ltd.: London, 1984.
- Perrin, D.D.; Dempsey, B.; Serjeant, E.P. pKa Prediction of Organic Acids and Bases; Chapman & Hall Ltd.: New York, 1981.
- Jenks, W.P. Catalysis in Chemistry and Enzymology; Dover Publications Inc.: Mineola, NY, 1987.
- Barry, B.W. Mode of action of penetration enhancers in human skin.J. Control. Release 1987, 6, 85–97., [CSA], [CROSSREF]
- Gore, A.V.; Liang, A.C.; Chien, Y.W. Comparative biomembrane permeation of tacrine using yucatan minipigs and domestic pigs as the animal model.J. Pharm. Sci. 1998, 87 (4), 441–447., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McMartin, C.; Hutchinson, L.E.F.; Hyde, R.; Peters, G.E. Analysis of the structural requirements for the absorption of drugs and macromolecules from the nasal cavity.J. Pharm. Sci. 1987, 76, 535., [CSA]
- Doshi, U.B.; Chiang, C.C.; Tojo, K.; Chien, Y.W. Mode of skin permeation. I. Effect of delipidization.Proc. Int. Symp. Control. Release Bioact. Mater. 1986, 13, 138., [CSA]
- Scheuplein, R.; Ross, L. Effect of surfactants and solvents on the permeability of epidermis.J. Soc. Cosmet. Chem. 1970, 21, 853–873., [CSA]
- Corbo, D.C.; Liu, J.; Chien, Y.W. Characterization of the barrier properties of mucosal membranes.J. Pharm. Sci. 1990, 79 (3), 202–206., [PUBMED], [INFOTRIEVE], [CSA]